Biolase Technology, Inc. (BIOL) Misses Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts BIOL Hot Sheet
Join SI Premium – FREE
Biolase Technology, Inc. (NASDAQ: BIOL) reported Q2 EPS of ($0.17), $0.09 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $10.2 million versus the consensus estimate of $12.97 million.
For earnings history and earnings-related data on Biolase Technology, Inc. (BIOL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Mannatech (MTEX) Tops Q2 EPS by 53c
- Stantec (STN) Tops Q2 EPS by 47c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
